Yingke Capital
Asia, Jiangxi, China, Fuzhou'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Yingke Capital is a professional equity investment institution.
Investor Profile
Yingke Capital has backed more than 12 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 21 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series D, Series C, Series B rounds (top funding stages).
- Majority of deals are located in China.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Series D (25%)
- Series C (25%)
- Series B (17%)
- Post Ipo Equity (8%)
- Series Unknown (8%)
- Private Equity (8%)
- Series A (8%)
Country Focus
- China (100%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Manufacturing
- Biopharma
- Pharmaceutical
- Electronics
- Machinery Manufacturing
- 3d Printing
- Automotive
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
